0001415889-17-000415.txt : 20170314
0001415889-17-000415.hdr.sgml : 20170314
20170314172617
ACCESSION NUMBER: 0001415889-17-000415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170312
FILED AS OF DATE: 20170314
DATE AS OF CHANGE: 20170314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ChromaDex Corp.
CENTRAL INDEX KEY: 0001386570
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 262940963
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10005 MUIRLANDS BLVD.
STREET 2: STE. G, FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-419-0288
MAIL ADDRESS:
STREET 1: 10005 MUIRLANDS BLVD.
STREET 2: STE. G, FIRST FLOOR
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: CODY RESOURCES, INC.
DATE OF NAME CHANGE: 20070112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fried Robert N
CENTRAL INDEX KEY: 0001417952
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37752
FILM NUMBER: 17689031
MAIL ADDRESS:
STREET 1: 100 NORTH CRESCENT DRIVE
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90210
4
1
form4-03142017_020307.xml
X0306
4
2017-03-12
0001386570
ChromaDex Corp.
CDXC
0001417952
Fried Robert N
10005 MUIRLANDS BLVD SUITE G
IRVINE
CA
92618
true
true
false
false
PRESIDENT, CHIEF STRATEGY OFF.
Common Stock
2017-03-12
4
A
0
339595
2.72
A
406574
D
Common Stock
2017-03-12
4
A
0
166667
0
A
573241
D
Common Stock
12744
I
See Footnote 3
Employee Stock Options (right to buy)
2.715
2017-03-12
4
A
0
500000
0
A
2017-04-12
2027-03-12
Common Stock
500000
500000
D
Received in exchange for the membership interests of Healthspan Research, LLC ("Healthspan") previously owned by the Reporting Person, valued at $923,697.41, in connection with the acquisition of the outstanding membership interests of Healthspan by ChromaDex Corporation (the "Company") (the "Acquisition"). The number of shares received by the Reporting Person was calculated using the closing bid price per share of the Company's common stock on the NASDAQ Capital Market on the last trading day before the effective date of the Acquisition, rounded up to the nearest share. The closing bid price of the Company's common stock on March 10, 2017, rounded up to the nearest share, was $2.72 per share.
These are shares of restricted stock and were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer. 1/3rd will vest on March 12, 2018, 1/3rd will vest on March 12, 2019 and 1/3rd will vest on March 12, 2020.
6,744 shares held by Jeremy Fried and 6,000 shares held by Benjamin Fried, who are both sons of Robert Fried.
The options were awarded pursuant to his employment with the issuer as President and Chief Strategy Officer.
Options vest in equal monthly installments over three years.
/s/ Robert Fried
2017-03-14